Richard S Levy Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Richard S Levy.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Richard S Levy. Richard S Levy is EVP, Chief Drug Dev Officer in INCYTE CORP ($INCY) and EVP, Chief Drug Dev&Medical Of in INCYTE CORP ($INCY) and Director in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and Director in ArTara Therapeutics, Inc. ($PRTO) and Director in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in Kodiak Sciences Inc. ($KOD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA).

Latest Insider Trading Transactions of Richard S Levy

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CNST, INCY, KNSA, KOD, SNTA, TARA

Page:   1 2 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 02 2020KODKodiak Sciences In ...Levy Richard SDirectorOption ExerciseA54.127,106384,5777,106
Jul 02 2020KNSAKiniksa Pharmaceut ...Levy Richard SDirectorOption ExerciseA25.4818,760478,00518,760
Jun 18 2020SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorOption ExerciseA111.066,000666,3606,000
Jun 11 2020TARAProtara Therapeuti ...Levy Richard SDirectorOption ExerciseA35.009,000315,0009,000
Jun 10 2020KODKodiak Sciences In ...Levy Richard SDirectorOption ExerciseA62.504,135258,4384,135
Apr 06 2020CNSTCONSTELLATION PHAR ...Levy Richard SDirectorOption ExerciseA30.2926,342797,89926,342
Mar 24 2020KODKodiak Sciences In ...Levy Richard SDirectorBuyP44.6575033,4881,000250 to 1,000 (+300.00 %)
Mar 24 2020KODKodiak Sciences In ...Levy Richard SDirectorBuyP43.3725010,8432500 to 250
Jan 13 2020PRTOArTara Therapeutic ...Levy Richard SDirectorGrantA0.0031,000031,0000 to 31 K
Jul 01 2019SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorOption ExerciseA100.4510,0001,004,50010,000
Jun 05 2019KODKodiak Sciences In ...Levy Richard SDirectorOption ExerciseA10.1324,747250,68724,747
Mar 06 2019KNSAKiniksa Pharmaceut ...Levy Richard SDirectorOption ExerciseA17.9237,965680,33337,965
Jun 21 2018SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorOption ExerciseA303.7910,0003,037,90010,000
Aug 24 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.2571149,1009.1 K to 9.1 K (+0.08 %)
Aug 24 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.121,79328,9039,0937.3 K to 9.1 K (+24.56 %)
Aug 24 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.111001,6117,3007.2 K to 7.3 K (+1.39 %)
Aug 24 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.081001,6087,2007.1 K to 7.2 K (+1.41 %)
Aug 23 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.141272,0507,1007 K to 7.1 K (+1.82 %)
Aug 23 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.122,94447,4576,9734 K to 7 K (+73.07 %)
Aug 23 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.103896,2634,0293.6 K to 4 K (+10.69 %)
Aug 23 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.99901,4393,6403.6 K to 3.6 K (+2.54 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.095909,4933,5503 K to 3.6 K (+19.93 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.074407,0712,9602.5 K to 3 K (+17.46 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.042103,3682,5202.3 K to 2.5 K (+9.09 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.022003,2042,3102.1 K to 2.3 K (+9.48 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.932003,1862,1101.9 K to 2.1 K (+10.47 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.90101591,9101.9 K to 1.9 K (+0.53 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.804006,3201,9001.5 K to 1.9 K (+26.67 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.792003,1581,5001.3 K to 1.5 K (+15.38 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.772003,1541,3001.1 K to 1.3 K (+18.18 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.721001,5721,1001,000 to 1.1 K (+10.00 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.701001,5701,000900 to 1,000 (+11.11 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.6790014,1039000 to 900
Jun 30 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorOption ExerciseA16.4610,000164,60010,000
Nov 21 2016SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorOption ExerciseA7.3620,000147,20020,000
Jan 08 2016INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM18.323,93772,1262,876
Jan 08 2016INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS101.863,937401,02316,92620.9 K to 16.9 K (-18.87 %)
Jan 08 2016INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM18.323,93772,12620,86316.9 K to 20.9 K (+23.26 %)
Dec 09 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM18.323,93772,1266,813
Dec 09 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS106.183,937418,03116,92620.9 K to 16.9 K (-18.87 %)
Dec 09 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM18.323,93772,12620,86316.9 K to 20.9 K (+23.26 %)
Nov 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM18.323,93672,10810,750
Nov 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS116.513,936458,58316,92620.9 K to 16.9 K (-18.87 %)
Nov 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM18.323,93672,10820,86216.9 K to 20.9 K (+23.25 %)
Oct 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM18.323,93772,12614,686
Oct 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS122.293,937481,45616,92620.9 K to 16.9 K (-18.87 %)
Oct 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM18.323,93772,12620,86316.9 K to 20.9 K (+23.26 %)
Sep 15 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS130.004,301559,13016,92621.2 K to 16.9 K (-20.26 %)
Sep 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM18.323,93772,12618,623
Sep 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS118.903,937468,10921,22725.2 K to 21.2 K (-15.65 %)
Sep 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM18.323,93772,12625,16421.2 K to 25.2 K (+18.55 %)
Aug 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM18.323,93672,10822,560
Aug 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS111.953,936440,63521,22725.2 K to 21.2 K (-15.64 %)
Aug 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM18.323,93672,10825,16321.2 K to 25.2 K (+18.54 %)
Jul 16 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM17.7970,2171,249,1600
Jul 16 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS120.0070,2178,426,04021,22791.4 K to 21.2 K (-76.79 %)
Jul 16 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM17.7970,2171,249,16091,44421.2 K to 91.4 K (+330.79 %)
Jul 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM18.323,93772,12626,496
Jul 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS107.003,937421,25921,22725.2 K to 21.2 K (-15.65 %)
Jul 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM18.323,93772,12625,16421.2 K to 25.2 K (+18.55 %)
Jun 23 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM17.7920,000355,80070,217
Jun 23 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS108.1320,0002,162,60021,22741.2 K to 21.2 K (-48.51 %)
Jun 23 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM17.7920,000355,80041,22721.2 K to 41.2 K (+94.22 %)
Jun 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM18.323,93772,12630,433
Jun 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS107.583,937423,54221,22725.2 K to 21.2 K (-15.65 %)
Jun 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM18.323,93772,12625,16421.2 K to 25.2 K (+18.55 %)
May 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM18.327,412135,78834,370
May 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS99.437,412736,97521,22728.6 K to 21.2 K (-25.88 %)
May 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM18.327,412135,78828,63921.2 K to 28.6 K (+34.92 %)
Apr 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM18.3225,000458,00041,782
Apr 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS88.7725,0002,219,25021,22746.2 K to 21.2 K (-54.08 %)
Apr 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM18.3225,000458,00046,22721.2 K to 46.2 K (+117.77 %)
Mar 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM18.3225,000458,00066,782
Mar 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS89.9125,0002,247,75021,22746.2 K to 21.2 K (-54.08 %)
Mar 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM18.3225,000458,00046,22721.2 K to 46.2 K (+117.77 %)
Oct 24 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM3.1113,90443,2410
Oct 24 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM3.1113,90443,24118,2054.3 K to 18.2 K (+323.27 %)
Oct 20 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM14.728,000117,76044,317
Oct 20 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS49.038,000392,2404,30112.3 K to 4.3 K (-65.04 %)
Oct 20 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM14.728,000117,76012,3014.3 K to 12.3 K (+186.00 %)
Sep 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM14.728,000117,76052,317
Sep 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS47.588,000380,6404,30112.3 K to 4.3 K (-65.04 %)
Sep 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM14.728,000117,76012,3014.3 K to 12.3 K (+186.00 %)
Aug 19 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM14.728,000117,76060,317
Aug 19 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS51.978,000415,7604,30112.3 K to 4.3 K (-65.04 %)
Aug 19 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM14.728,000117,76012,3014.3 K to 12.3 K (+186.00 %)
Jul 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM14.728,000117,76068,317
Jul 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS48.158,000385,2004,30112.3 K to 4.3 K (-65.04 %)
Jul 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM14.728,000117,76012,3014.3 K to 12.3 K (+186.00 %)
Jun 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM14.728,000117,76076,317
Jun 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS53.888,000431,0404,30112.3 K to 4.3 K (-65.04 %)
Jun 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM14.728,000117,76012,3014.3 K to 12.3 K (+186.00 %)
May 20 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM14.728,000117,76084,317
May 20 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS50.688,000405,4404,30112.3 K to 4.3 K (-65.04 %)
May 20 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM14.728,000117,76012,3014.3 K to 12.3 K (+186.00 %)
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM13.344175,5630
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM13.3414,583194,5370
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM9.4124,787233,2460
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM11.981,94523,3010
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM11.989,138109,4730
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM9.4112,300115,7430
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM11.9825,862309,8270
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM9.4147,913450,86124,787
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM3.1161,096190,0090
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM11.9833,055395,9990
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS66.1339,7872,631,1144,30144.1 K to 4.3 K (-90.24 %)
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM13.344175,56344,08843.7 K to 44.1 K (+0.95 %)
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM13.3414,583194,53743,67129.1 K to 43.7 K (+50.13 %)
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM9.4124,787233,24629,0884.3 K to 29.1 K (+576.31 %)
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS66.38191,30912,699,0914,301195.6 K to 4.3 K (-97.80 %)
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM11.981,94523,301195,610193.7 K to 195.6 K (+1.00 %)
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM11.989,138109,473193,665184.5 K to 193.7 K (+4.95 %)
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM9.4112,300115,743184,527172.2 K to 184.5 K (+7.14 %)
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM11.9825,862309,827172,227146.4 K to 172.2 K (+17.67 %)
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM9.4147,913450,861146,36598.5 K to 146.4 K (+48.67 %)
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM3.1161,096190,00998,45237.4 K to 98.5 K (+163.55 %)
Feb 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM11.9833,055395,99937,3564.3 K to 37.4 K (+768.54 %)
Jan 23 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseA64.5534,8682,250,72934,868
Jan 23 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseA64.5599764,356997
Sep 09 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM11.9825,000299,500862
Sep 09 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS35.2825,000882,000025 K to 0 (-100.00 %)
Sep 09 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM11.9825,000299,50025,0000 to 25 K
May 15 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM7.094,30130,4940
May 15 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM7.0955,699394,9060
May 15 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS22.3055,6991,242,0884,30160 K to 4.3 K (-92.83 %)
May 15 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM7.094,30130,49460,00055.7 K to 60 K (+7.72 %)
May 15 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM7.0955,699394,90655,6990 to 55.7 K
Feb 20 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM8.9938,440345,5760
Feb 20 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM5.4616,25188,7300
Feb 20 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM5.4643,749238,8700
Feb 20 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS22.4898,4402,212,931098.4 K to 0 (-100.00 %)
Feb 20 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM8.9938,440345,57698,44060 K to 98.4 K (+64.07 %)
Feb 20 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM5.4616,25188,73060,00043.7 K to 60 K (+37.15 %)
Feb 20 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM5.4643,749238,87043,7490 to 43.7 K
Feb 12 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseA18.32141,7822,597,446141,782
Feb 12 2013INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseA18.328,218150,5548,218
May 01 2012INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM8.198,44069,1240
May 01 2012INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM8.999,75187,66138,440
May 01 2012INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM8.9911,809106,1630
May 01 2012INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS22.9530,000688,500030 K to 0 (-100.00 %)
May 01 2012INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM8.198,44069,12430,00021.6 K to 30 K (+39.15 %)
May 01 2012INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM8.999,75187,66121,56011.8 K to 21.6 K (+82.57 %)
May 01 2012INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM8.9911,809106,16311,8090 to 11.8 K
Jan 23 2012INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseA17.7993,9001,670,48193,900
Jan 23 2012INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseA17.796,100108,5196,100
Jan 27 2011INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseA14.7292,3171,358,90692,317
Jan 27 2011INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseA14.727,683113,0947,683
Jan 20 2011INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM8.1925,310207,2890
Jan 20 2011INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM4.1915,00062,8500
Jan 20 2011INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS15.776,400100,92806.4 K to 0 (-100.00 %)

Page:   1 2 next >